 | Up a level |
Metral, M; Nadin, I; Locatelli, I; Tarr, P E; Calmy, A; Kovari, H; Brugger, P; Cusini, A; Gutbrod, K; Schmid, P; Schwind, M; Kunze, U; Di Benedetto, C; Pignatti, R; Du Pasquier, R; Darling, Kea; Cavassini, M (2020). How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? HIV medicine, 21(5), pp. 342-348. Wiley 10.1111/hiv.12828
Métral, M; Darling, Kea; Locatelli, I; Nadin, I; Santos, G; Brugger, P; Kovari, H; Cusini, Alexia; Gutbrod, Klemens; Tarr, P E; Calmy, A; Lecompte, T D; Assal, F; Monsch, A; Kunze, U; Stoeckle, M; Schwind, M; Schmid, P; Pignatti, R; Di Benedetto, C; ... (2020). The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile. HIV medicine, 21(1), pp. 30-42. Wiley 10.1111/hiv.12795
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073
